Longtime Northwestern University research benefactor Kimberly Querrey is giving $10 million to launch an institute for ...

Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis (LN) ...

YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...

British Columbians can give back to an important local cause while enjoying a delectable candy treat! Huer Foods?a local candy brand based in BC's Lower Mainland?has launched a special edition candy ...

Cambrex, a New Jersey-based global contract development and manufacturing organization (CDMO), celebrated the grand opening ...

In Q1, the company submitted a supplemental Biologics License Application (sBLA) for use of ANKTIVA® plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) ...

The market is forecasted to grow robustly until 2035, identifying key players and their potential. The report highlights the increasing demand for specialized logistics solutions due to the complexity ...

Each Unit consists of one Common Share and one Warrant ... the Company advancing towards clinical and commercial breakthroughs in regenerative medicine; the Company enhancing its presence in key ...

ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia: Culver City, Calif Thursday, April 17, 2025, 15:00 Hrs [IST] ...

The regenerative role of the adult stem cell secretome is a burgeoning area of research with significant therapeutic potential. These secretomes, which ...

Introduction NurExone (TSXV:NRX) an innovative Canadian biopharmaceutical company, has reached a significant milestone in its efforts to revolutionize spinal cord injury treatments. The company ...